Literature DB >> 23312343

Complete but not partial thymectomy in early infancy reduces T-cell-mediated immune response: three-year tracing study after pediatric cardiac surgery.

Hirotsugu Kurobe1, Takashi Tominaga, Mikio Sugano, Yasunobu Hayabuchi, Yoshiyasu Egawa, Yousuke Takahama, Tetsuya Kitagawa.   

Abstract

OBJECTIVE: Thymectomy is often performed to secure an operative field in surgery for congenital heart defects in early infancy. However, how neonatal thymectomy affects the subsequent development of the immune system in humans remains unclear. We monitored patients for 3 years from the time of thymectomy that was performed during cardiac surgery in early infancy.
METHODS: For up to 3 years, we monitored the number of circulating lymphocytes and the clinical course of the children who underwent complete (n = 17), partial, and no (n = 15) thymectomy during congenital heart defect surgery performed at less than 3 months of age. The titers of immunoglobulin-G produced in response to vaccinated viruses and phytohemagglutinin responses were also measured.
RESULTS: Six months after surgery, the number of T cells, including CD4(+) and CD8(+) subpopulations, decreased in patients with complete but not partial thymectomy. The reduction in T-cell number persisted for 3 years, whereas the number of B cells did not change. In patients with complete thymectomy, the titers of immunoglobulin-G produced in response to vaccinated measles and rubella viruses were reduced, whereas the phytohemagglutinin-induced proliferation of T cells was not impaired. In addition, hospitalization frequency associated with infectious diseases increased in patients with complete but not partial thymectomy.
CONCLUSIONS: The results revealed that complete thymectomy in early infancy reduces the number of circulating T cells and T-cell-mediated immune responses for at least 3 years, suggesting that the thymus should be at least partially preserved during surgery in early infancy to maintain protective immunity.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312343     DOI: 10.1016/j.jtcvs.2012.12.015

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient.

Authors:  K Puri; S Kocoshis; K Risma; L Perez; C Hart; C Chin; T D Ryan; J L Jefferies; K R Schumacher; C Castleberry
Journal:  Pediatr Transplant       Date:  2015-09-16

2.  Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.

Authors:  Diego Sánchez-Martínez; Matteo L Baroni; Francisco Gutierrez-Agüera; Heleia Roca-Ho; Oscar Blanch-Lombarte; Sara González-García; Montserrat Torrebadell; Jordi Junca; Manuel Ramírez-Orellana; Talía Velasco-Hernández; Clara Bueno; José Luís Fuster; Julia G Prado; Julien Calvo; Benjamin Uzan; Jan Cools; Mireia Camos; Françoise Pflumio; María Luisa Toribio; Pablo Menéndez
Journal:  Blood       Date:  2019-02-22       Impact factor: 22.113

3.  T Cell Response to Influenza Vaccination Remains Intact in Adults with Congenital Heart Disease Who Underwent Early Thymectomy.

Authors:  David M Leone; Hong-Jai Park; Serhan Unlu; Michelle Gurvitz; Insoo Kang; Robert W Elder
Journal:  Int J Cardiol Congenit Heart Dis       Date:  2022-03-25

4.  Medical Therapies for Heart Failure in Hypoplastic Left Heart Syndrome.

Authors:  Angela N Baybayon-Grandgeorge; Ashley E Pietra; Shelley D Miyamoto; Anastacia M Garcia
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-12

Review 5.  Control of the thymic medulla and its influence on αβT-cell development.

Authors:  Beth Lucas; Nicholas I McCarthy; Song Baik; Emilie Cosway; Kieran D James; Sonia M Parnell; Andrea J White; William E Jenkinson; Graham Anderson
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

6.  IL-7-Induced Proliferation of Human Naive CD4 T-Cells Relies on Continued Thymic Activity.

Authors:  Susana L Silva; Adriana S Albuquerque; Paula Matoso; Bénédicte Charmeteau-de-Muylder; Rémi Cheynier; Dário Ligeiro; Miguel Abecasis; Rui Anjos; João T Barata; Rui M M Victorino; Ana E Sousa
Journal:  Front Immunol       Date:  2017-01-19       Impact factor: 7.561

Review 7.  The significance of neonatal thymectomy for shaping the immune system in children with congenital heart defects.

Authors:  Małgorzata Stosio; Jakub Ruszkowski; Anna Mikosik-Roczyńska; Ireneusz Haponiuk; Jacek M Witkowski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-12-20

Review 8.  Thymus Regeneration and Future Challenges.

Authors:  Valentin P Shichkin; Mariastefania Antica
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

9.  Risk factors for pediatric surgical site infection following neurosurgical procedures for hydrocephalus: a retrospective single-center cohort study.

Authors:  Thomas J Sandora; Koichi Yuki; Miho Shibamura-Fujiogi; Jennifer Ormsby; Mark Breibart; Benjamin Warf; Gregory P Priebe; Sulpicio G Soriano
Journal:  BMC Anesthesiol       Date:  2021-04-21       Impact factor: 2.217

Review 10.  Neutrophil and T Cell Functions in Patients with Congenital Heart Diseases: A Review.

Authors:  Koichi Yuki; Sophia Koutsogiannaki
Journal:  Pediatr Cardiol       Date:  2021-07-20       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.